The University of Chicago Header Logo

Connection

Ernst Lengyel to Sulfonamides

Back to Details
This is a "connection" page, showing publications Ernst Lengyel has written about Sulfonamides.
Ernst Lengyel
Connection Strength
0.785
Sulfonamides
  1. Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth. Mol Cancer Ther. 2025 Aug 01; 24(8):1252-1264.
    View in: PubMed
    Score: 0.785
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.